Related Practices
Activities
|
Biography
Soo Y. Kim focuses her practice in complex litigation on both the state and federal level. Ms. Kim has actively managed cases in all phases from pre-suit investigation, pre-trial discovery and up to trial. Ms. Kim’s practice is predominantly focused on the defense of pharmaceutical and medical device manufacturers, where Ms. Kim worked on both litigation as well as managed the administration of settlements of pharmaceutical mass tort litigation in the U.S. and Canada.
Soo Y. Kim focuses her practice in complex litigation on both the state and federal level. Ms. Kim has actively managed cases in all phases from pre-suit investigation, pre-trial discovery and up to trial. Ms. Kim’s practice is predominantly focused on the defense of pharmaceutical and medical device manufacturers, where Ms. Kim worked on both litigation as well as managed the administration of settlements of pharmaceutical mass tort litigation in the U.S. and Canada.
Ms. Kim’s experience also includes the defense of commercial clients in healthcare and toxic tort litgation.
Prior to joining Sedgwick, Ms. Kim served as a law clerk to The Honorable Stephen G. Milliken of the Superior Court of the District of Columbia and The Honorable J. Ramsey Johnson of the Superior Court of the District of Columbia.
Presentations & Publications
Ms. Kim's presentations include:
- Presenter, “Off-Label Information: Regulation & Dissemination,” audioconference sponsored by FX Conferences, (September 3, 2009).
Ms. Kim's publications include:
- “Preventive Medicine,” MD+DI, (July 2010).
- "Question of Preemptive Effect of Vaccine Act Before Supreme Court," Sedgwick's Issue Tracker (March 2010).
- "NJ Considering New Regulations of Drug and Medical Device Industry's Financial Relationships With Physicians," Sedgwick's Issue Tracker (March 2010).
-
-
“Scratching Below the Surface: New Role for Expert Testimony and the ‘Daubert’ Hearing,” New York Law Journal (May 18, 2009).
-
-
“Drug Manufacturer Not Entitled to Preemption Defense in Warning Case,” Sedgwick Drug and Medical Device Alert (March 4, 2009).
-
"FTC: Drug Manufacturers Must Not Only Review What They Say, But How They Say It," Sedgwick's Pharmaceutical Newsletter (Spring 2007).
-
"New Labeling and 'Adverse Reactions': Implications for Product Liability Suits," Pharmaceutical Law & Industry Report, Bureau of National Affairs (June 2006) (coauthor).
-
"Get Off the Witness Stand! Keeping Testimony Interesting," authored by Eric M. Kraus (parter, Sedgwick New York), Trials and Tribulations, Defense Research Institute (Winter 2003) (significant contributor of content).
Memberships & Honors
While in law school, Ms. Kim was an articles editor for the American Intellectual Property Law Association Quarterly Journal.
Areas of Concentration
Mass Tort & Complex Litigation; Products Liability; Medical Malpractice; General Litigation
Admissions
New York;
U.S. District Court (E.D.N.Y.); U.S. District Court (S.D.N.Y.)
Education
J.D.
(1999)
George Washington University Law School
A.B.
(1995)
Georgetown University,
with honors
|